AIM IMMUNOTECH INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
AIM IMMUNOTECH INC. (AIM) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $2.94 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2016-11-14
- AIM IMMUNOTECH INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $1.39M, a 42.99% decline year-over-year.
- AIM IMMUNOTECH INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $1.61M.
- AIM IMMUNOTECH INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was -$60.00K.
- AIM IMMUNOTECH INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-12-31 was $4.27M.
- AIM IMMUNOTECH INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $6.35M, a 150.67% increase from fiscal 2014.
- AIM IMMUNOTECH INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $2.53M, a 88.66% decline from fiscal 2013.
- AIM IMMUNOTECH INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was $22.34M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2016-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $3.00M derived: sum of 2 quarters · filed 2016-11-14 | $2.94M 10-Q · filed 2016-11-14 | $7.21M derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-06-30 | $1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $1.55M 10-Q · filed 2016-08-15 | $5.82M derived: sum of 3 quarters · filed 2016-08-15 | $8.26M derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-03-31 | -$60.00K 10-Q · filed 2016-05-16 | $4.21M derived: sum of 2 quarters · filed 2016-05-16 | $6.65M derived: sum of 3 quarters · filed 2016-11-14 | $6.48M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-12-31 | $4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $6.71M derived: sum of 2 quarters · filed 2016-11-14 | $6.54M derived: sum of 3 quarters · filed 2016-11-14 | $6.35M 10-K · filed 2016-03-29 |
| 2015-09-30 | $2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $2.27M derived: sum of 2 quarters · filed 2016-11-14 | $2.08M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -$163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$355.00K 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | -$192.00K 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | $2.53M 10-K · filed 2016-03-29 | |||
| 2013-12-31 | $22.34M 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |